Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 247 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-TADALAFIL | 20MG | TABLET | Resolved | 2019-07-17 | 2020-01-10 | 89551 |
APO-ACYCLOVIR | 400MG | TABLET | Resolved | 2019-07-17 | 2019-08-30 | 89570 |
APO-ENALAPRIL | 2.5MG | TABLET | Resolved | 2019-08-07 | 2019-12-19 | 91078 |
APO-LAMOTRIGINE | 150MG | TABLET | Resolved | 2019-08-07 | 2019-08-21 | 91081 |
APO-NALTREXONE | 50MG | TABLET | Resolved | 2019-08-07 | 2019-08-19 | 91091 |
APO-ONDANSETRON | 4MG | TABLET | Resolved | 2019-08-07 | 2019-11-11 | 91094 |
APO-ONDANSETRON | 8MG | TABLET | Resolved | 2019-08-07 | 2019-11-11 | 91097 |
APO-QUINAPRIL/HCTZ | 12.5MG 10MG | TABLET | Resolved | 2019-08-07 | 2019-09-23 | 91103 |
APO-TADALAFIL PAH | 20MG | TABLET | Resolved | 2019-08-07 | 2019-12-19 | 91106 |
TRI-CIRA LO 28 | 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG | TABLET | Resolved | 2019-08-07 | 2019-08-26 | 91109 |
APO-CLOPIDOGREL | 300MG | TABLET | Resolved | 2019-08-14 | 2019-10-15 | 91532 |
APO-EZETIMIBE | 10MG | TABLET | Resolved | 2019-08-14 | 2019-10-07 | 91535 |
OVIMA 21 | 30MCG 150MCG | TABLET | Resolved | 2019-08-19 | 2019-09-05 | 91923 |
ACETAMINOPHEN CAPLETS 500 MG | 500MG | TABLET | Resolved | 2019-08-21 | 2019-10-07 | 92010 |
APO-ABACAVIR-LAMIVUDINE | 600MG 300MG | TABLET | Resolved | 2019-08-21 | 2020-01-27 | 92016 |
APO-QUINAPRIL/HCTZ | 25MG 20MG | TABLET | Resolved | 2019-08-21 | 2019-09-16 | 92032 |
APO-TAMOX TAB 10MG | 10MG | TABLET | Resolved | 2019-08-21 | 2019-12-07 | 92035 |
APO-TADALAFIL | 5MG | TABLET | Resolved | 2019-08-23 | 2020-01-22 | 92387 |
APO-DEXAMETHASONE | 4MG | TABLET | Resolved | 2019-08-28 | 2020-09-09 | 92513 |
APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2019-08-28 | 2020-02-19 | 92522 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2019-06-12 | 40778 |
APO-METFORMIN | 500MG | TABLET | To be discontinued | 2018-02-23 | 2018-12-28 | 40781 |
APO-METFORMIN | 500MG | TABLET | To be discontinued | 2018-02-23 | 2018-12-28 | 40784 |
APO-METFORMIN | 500MG | TABLET | Discontinued | 2018-02-23 | 2018-11-26 | 40790 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40796 |
APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40811 |
APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40814 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40817 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40820 |
APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40823 |
APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40826 |
APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40829 |
APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40832 |
APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-02-28 | 40835 |
APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40838 |
ANTI-NAUSEANT | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-09-12 | 40841 |